Researchers in Hong Kong find ulcer drug could be effective in halting coronavirus replication

Subscribe to our YouTube channel for free here: sc.mp/subscribe-youtube A University of Hong Kong study has found that ranitidine bismuth citrate, or RBC, a drug commonly used to treat stomach ulcers, shows promise in preventing the SARS-CoV-2 coronavirus from replicating in an animal model. The researchers said RBC's effectiveness is comparable to the outcome of the coronavirus drug remdesivir, but at a much lower cost. Support us: subscribe.scmp.com/ Follow us on: Website: www.scmp.com/ Facebook: facebook.com/scmp Twitter: twitter.com/scmpnews Instagram: instagram.com/scmpnews Linkedin: www.linkedin.com/company/south-china-morning-post/

• #news_politics
• #coronaivurs
• #covid_19
• #coronavirus_hong_kong
• #covid_19_hong_kong
• #coronavirus_drug
• #covid_19_drug
• #coronavirus_drug_hong_kong
• #covid_19_drug_hong_kong
• #rbc
• #ranitidine_bismuth_citrate
• #remdesivir
• #hong_kong_rbc